Douglas Hughes
Director/Board Member at IMMUNOVANT, INC.
Net worth: 2 M $ as of 2024-01-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jee Shin | F | - |
Calyxo, Inc.
 Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| George Migausky | M | 69 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
| Atul Pande | M | 69 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
| Peter Salzmann | M | 56 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
| Andrew Fromkin | M | 58 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
| Julia G. Butchko | M | 53 | 5 years | |
| Eva Barnett | F | 44 | 3 years | |
| Mark Levine | M | 51 | 2 years | |
| Katherine Bayne | F | 57 | 3 years | |
| Frank Torti | M | 45 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 years |
| Maria Alba | M | - | - | |
| Ian Gourley | M | - | - | |
| Sheetal Patel | F | - | - | |
| Fred Knight | M | - | 2 years | |
| Judy Roth | F | - | - | |
| Jennifer Moseley | F | - | - | |
| Lauren Schrier | F | - | - | |
| Karr Narula | M | 44 | 2 years | |
| Michael Elliott | M | - | 4 years | |
| Jay Stout | M | 61 | 1 years | |
| Eric Venker | M | 37 | 4 years | |
| Douglas Hughes | M | - |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Trit Garg | M | 34 | 2 years | |
| Robert Goforth | M | - |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Justin Sabet-Peyman | M | 41 | 2 years | |
| William L. Macias | M | 66 | 3 years | |
| Theodore M. Bender | M | - |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | 11 years |
| Joseph Catanese | M | - |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Chau Cheng | M | - | - | |
| Ryan Drant | M | 53 |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Donald Spence | M | 70 | 2 years | |
| Beverly A. Huss | F | 64 |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Andy Deig | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joshua Makower | M | 60 | 7 years | |
| David Amerson | M | - |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| Brooke Seawell | M | 76 | 2 years | |
| Pamela Connealy | F | 63 | 2 years | |
| Geoff B. Pardo | M | 52 | 1 years | |
| Peter Bisgaard | M | 50 | 5 years | |
| Robert D. Mitchell | M | 62 |
Nellix, Inc.
 Nellix, Inc. Medical SpecialtiesHealth Technology Nellix, Inc. develops novel solutions to vascular diseases. It develops endograft products for the treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. The company was founded in 2001 and is headquartered in Palo Alto, CA. | 2 years |
| Nina Richardson | F | 65 | 2 years | |
| Sandeep Kulkarni | M | 43 | 2 years | |
| John Strumbos | M | - | 2 years | |
| Tracy Newbold | F | - | - | |
| Ajit Pillaiu | M | - | 5 years | |
| Rita Jain | M | 61 | - | |
| Tyler Binney | M | - |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| Jason Throne | M | 53 |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | 2 years |
| Wendy J. Sawyer | F | - |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| Juliet Bakker | F | 62 | 1 years | |
| William M. Facteau | M | 53 |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| Guido Neels | M | 75 |
Nellix, Inc.
Nellix, Inc. Medical SpecialtiesHealth Technology Nellix, Inc. develops novel solutions to vascular diseases. It develops endograft products for the treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. The company was founded in 2001 and is headquartered in Palo Alto, CA. | 4 years |
| Kevin O'Boyle | M | 68 |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| W. Middlekauff | M | 63 | 1 years | |
| Myrtle Potter | F | 65 | - | |
| Tom Dorney | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 56 | 100.00% |
| Bermuda | 5 | 8.93% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas Hughes
- Personal Network